These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37908671)

  • 41. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
    Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
    Front Immunol; 2020; 11():1037. PubMed ID: 32547550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Twindrive Precise Delivery System of Platelet-Neutrophil Hybrid Membrane Regulates Macrophage Combined with CD47 Blocking for Postoperative Immunotherapy.
    Sheng S; Jin L; Zhang Y; Sun W; Mei L; Zhu D; Dong X; Lv F
    ACS Nano; 2024 Feb; 18(6):4981-4992. PubMed ID: 38193386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.
    Rodell CB; Arlauckas SP; Cuccarese MF; Garris CS; Li R; Ahmed MS; Kohler RH; Pittet MJ; Weissleder R
    Nat Biomed Eng; 2018 Aug; 2(8):578-588. PubMed ID: 31015631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibroblast Activation Protein-α Responsive Peptide Assembling Prodrug Nanoparticles for Remodeling the Immunosuppressive Microenvironment and Boosting Cancer Immunotherapy.
    Sun M; Yao S; Fan L; Fang Z; Miao W; Hu Z; Wang Z
    Small; 2022 Mar; 18(9):e2106296. PubMed ID: 34914185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted delivery of reduced graphene oxide nanosheets using multifunctional ultrasound nanobubbles for visualization and enhanced photothermal therapy.
    Liu Z; Zhang J; Tian Y; Zhang L; Han X; Wang Q; Cheng W
    Int J Nanomedicine; 2018; 13():7859-7872. PubMed ID: 30538464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Augmenting Immunogenic Cell Death and Alleviating Myeloid-Derived Suppressor Cells by Sono-Activatable Semiconducting Polymer Nanopartners for Immunotherapy.
    Ding M; Zhang Y; Yu N; Zhou J; Zhu L; Wang X; Li J
    Adv Mater; 2023 Aug; 35(33):e2302508. PubMed ID: 37165741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis.
    Qiu Y; Wu Z; Chen Y; Liao J; Zhang Q; Wang Q; Duan Y; Gong K; Chen S; Wang L; Fan P; Duan Y; Wang W; Dong Y
    Adv Sci (Weinh); 2023 Jul; 10(21):e2300878. PubMed ID: 37162268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment.
    Kong C; Xu B; Qiu G; Wei M; Zhang M; Bao S; Tang J; Li L; Liu J
    Int J Nanomedicine; 2022; 17():5391-5411. PubMed ID: 36419717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
    Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
    J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrated platform of oxygen self-enriched nanovesicles: SP94 peptide-directed chemo/sonodynamic therapy for liver cancer.
    Zhang W; Han B; Gao C; Liu X; Peng Y; Gong C; Hu D; Wang N; Tang S; Zhang B; Zhao M; Peng H
    Eur J Pharm Biopharm; 2022 Oct; 179():206-220. PubMed ID: 36150614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 54. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
    Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
    Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
    J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chimeric Peptide Engineered Bioregulator for Metastatic Tumor Immunotherapy through Macrophage Polarization and Phagocytosis Restoration.
    Chen XY; Yan MY; Liu Q; Yu BX; Cen Y; Li SY
    ACS Nano; 2023 Aug; 17(16):16056-16068. PubMed ID: 37578051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors.
    Bahmani B; Gong H; Luk BT; Haushalter KJ; DeTeresa E; Previti M; Zhou J; Gao W; Bui JD; Zhang L; Fang RH; Zhang J
    Nat Commun; 2021 Mar; 12(1):1999. PubMed ID: 33790276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Strategies and challenges of immunotherapy for hepatocellular carcinoma].
    Zhang HH; Chen HS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):457-460. PubMed ID: 32660170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook.
    Zhou Z; Hu Y; Wu Y; Qi Q; Wang J; Chen L; Wang F
    Mol Immunol; 2022 Nov; 151():218-230. PubMed ID: 36179604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.